Allied sales rise 13% to $3.7 mn in H2, 2012

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 22 Feb, 2013

Singapore: Australia-based Allied Healthcare has marked a stronger sales with revenues up at 13 percent to $3.7 million for six months ending December 31, 2012, as compared to $3.319 millio...Read more

Australia launches nanotech R&D plan

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 07 Dec, 2012

Singapore: Senator Kate Lundy, the Australian minister assisting for industry and innovation,  has launched Australian Academy of Science's National Nanotechnology Research Strategy. Prep...Read more

AtCor wins $1.1 mn contract for SphygmoCor system

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 21 Aug, 2012

Singapore: Australian firm AtCor Medical, a developer and marketer of the SphygmoCor system that measures central aortic blood pressures and arterial stiffness noninvasively, has signed a ...Read more

ResMed launches sleep apnea device in the US

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 15 Jun, 2012

Singapore: ResMed, Australian developer, manufacturer and distributor of sleep and respiratory medical equipment, has launched Narval CC, its state-of-the-art mandibular repositioning devi...Read more

Invida gets COPD drug rights in Australia, NZ

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 17 Oct, 2012

Singapore: Almirall granted commercial rights for Aclidinium in Australia and New Zealand for the treatment of chronic obstructive pulmonary disorder (COPD) to Invida Holdings. Although th...Read more

Viralytics commences trading on US OTCQX

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 05 Aug, 2013

Singapore: Viralytics' American Depository Receipts (ADRs) have commenced trading on OTCQX International. ADRs trade under the symbol 'VRACY' and each ADR represents three ordinary shares. ...Read more

Allied applies for heart patch approval in US

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 02 Apr, 2013

Singapore: Allied Healthcare has lodged its Premarket Notification 510(k) Submission for CardioCel in the US. The FDA 510(K) submission is a major step in Allied's strategy to gain marketin...Read more

Distinguished AIDS researcher, Prof Joep Lange, dies in MH17 crash

Australia |  Influencers | By BioSpectrum Bureau  | 0 Comment | 18 Jul, 2014

Singapore: Eminent AIDS researcher, Prof Joep Lange, died in the Malaysian Airlines flight MH17 crash on July 17 while he was enroute to Melbourne to attend 20th International AIDS Conferen...Read more

New tech promises revenue boost for drug makers

Australia |  Influencers | By BioSpectrum Bureau  | 0 Comment | 12 Jun, 2013

Australian drug delivery technology company Imugene has developed Linguet, a drug delivery technology platform, to improve efficacy and safety of existing prescriptions and over-the-counter...Read more

Mr Paul Wright, Universal Biosensors: Point-of-care-diagnostics will continue to grow in 2013

Australia |  Opinion | By BioSpectrum Bureau  | 0 Comment | 26 Dec, 2012

I think there will be continuing of existing trends in 2013 as well. We expect to see ongoing growth in the point-of-care-diagnostics (POCD) market. I also expect continued integration of d...Read more

World leader discuss health challenges at Qatar

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 11 Dec, 2013

Singapore: World leaders and policy makers have gathered in Doha, Qatar, to discuss innovative solutions to the most pressing global health challenges at the inaugural World Innovation Summ...Read more

Aussie firm Mayne to acquire GSK's Kapanol

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 07 Jan, 2013

Singapore: Australia's Mayne Pharma plans to acquire Kapanol and related assets in Australia from GlaxoSmithKline (GSK). Under the terms of the agreement, Mayne Pharma will acquire the Kap...Read more

Patrys progresses myeloma trial to patient group

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 18 Jan, 2013

Singapore: Patrys, a clinical stage biopharmaceutical company, received approval to progress its phase I/IIa PAT-SM6 multiple myeloma trial based on safety data from its first group of pat...Read more

AtCor to report full year maiden profit

Australia |  Company results | By BioSpectrum Bureau  | 0 Comment | 22 Jul, 2013

Singapore: AtCor Medical, the developer and marketer of the SphygmoCor system that measures central blood pressures and arterial stiffness non-invasively, revealed unaudited FY2013 sales of...Read more

Starpharma's new condom gel will fight STIs

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 21 Jul, 2014

Singapore: Australia's biotechnology company, Starpharma has received a regulatory approval for the sale of its revolutionary new product in the country. The company has developed a virus-...Read more

Russell Howard to join Prima BioMed board

Australia |  Influencers | By BioSpectrum Bureau  | 0 Comment | 09 May, 2013

Singapore: Prima BioMed has appointed Dr Russell J Howard as a non-executive director with immediate effect. Dr Howard brings a strong scientific background and significant executive-level ...Read more

Prana provides update on Huntington Disease trial

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 15 Nov, 2012

Singapore: Melbourne-based Prana Biotechnology released an update on the Huntington Disease trial. The company reported the progress in the Reach2HD trial at the Huntington Study Group Annu...Read more

Starpharma to receive $6 mn for overseas R&D

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 23 Nov, 2012

Singapore: Australia-based Starpharma is eligible to receive approximately $6 million cash in R&D tax incentives for overseas research activities related to VivaGel. Starpharma has made...Read more